Testosterone_gel: profile and news






BioSante Pharmaceuticals to Present Bio-E-Gel(R) and Corporate ...  May 10, 2006
...include Bio-E-Gel(R) (transdermal estradiol gel) for the treatment of women with menopausal symptoms, and LibiGel(R) (transdermal testosterone gel) for the ... - Genetic Engineering News,

Rodman & Renshaw 3rd Annual Global Healthcare Conference 2006 ...  May 11, 2006
...most advanced drug-delivery technology, CPE-215, has already led to the development of a marketed product, TESTIM, a topical testosterone gel licensed to ... - Genetic Engineering News,

Oscient Pharmaceuticals Reports Financial Results for First ...  May 9, 2006
...also recorded approximately $1.5 million in revenue from the Company's co-promotion agreement with Auxilium Pharmaceuticals for TESTIM(R) 1% testosterone gel. ... - Genetic Engineering News,

Auxilium Pharmaceuticals, Inc. Announces First Quarter 2006 ...  May 9, 2006
Auxilium markets TestimĀ® 1%, a topical testosterone gel, for the treatment of hypogonadism through its approximately 130-person sales and marketing team. ... - Yahoo! News (press release)

Wall Street al Cierre de Europa  May 9, 2006
...[+]. (BMS) - EE.UU.: Watson Pharmaceuticals adquiere Andrx Corp.... [. MT) - Watson Pharma Gets FDA Approval To Test Generic Testosterone Gel... [+. ... - Bolsamania.com,

A boost for Women's sex drives  May 1, 2006
Three methods, parenteral, testosterone patches, and testosterone gel all demonstrated increases in ability to orgasm, and frequency of sexual intercourse. ... - Newindpress (subscription),

Cellegy's licensee for Tostrex in Europe has reported successful ...  May 4, 2006
April 7, 2006. Tostrex is a 2% topical testosterone gel indicated for the treatment of male hypogonadism. ProStrakan's announcement ... - Therapeutics Daily (subscription) (press release),

Webcast Alert: Oscient Pharmaceuticals Announces Date for Release ...  Apr 20, 2006
The Company is also promoting Auxilium Pharmaceuticals' TESTIM(R) 1% testosterone gel to primary care physicians in the US Oscient has a novel antibiotic ... - Genetic Engineering News,

Auxilium Pharmaceuticals to Present at UBS Specialty ...  Apr 20, 2006
Auxilium markets TestimĀ® 1%, a topical testosterone gel, for the treatment of hypogonadism through its approximately 120-person sales and marketing team. ... - Yahoo! News (press release)


Home | About | Cancers | Treatment | Medications
Copyright onconews.org 2005.
All Rights Reserved.
Google
 
Web onconews.org